 VistaGen Therapeutics, Inc. NASDAQ:VTGN Q1 2023 Earnings Conference Call August 11, 2022 5:00 PM ET Company Participants Mark Flather Vice President-Investor Relations Shawn Singh Chief Executive Officer Jerry Dotson Chief Financial Officer Conference Call Participants Brian Skorney Baird Operator Welcome to the VistaGen Therapeutics First Quarter Fiscal Year 2023 Results Conference Call. Operator Instructions Ill now turn the call over to your host, Mark Flather, Vice President of Investor Relations. 